LBF20503HO09: Difference between revisions
No edit summary |
No edit summary |
||
| (7 intermediate revisions by the same user not shown) | |||
| Line 5: | Line 5: | ||
{{Metabolite | {{Metabolite | ||
|LipidBank=DFA8118 | |LipidBank=DFA8118 | ||
|LipidMaps= | |LipidMaps=- | ||
|SysName=5S- | |SysName=5S-Hydroxy- (trans-6,cis-8,cis-11,cis-14,cis-17) -eicosapentaenoic acid | ||
|Common Name=&&5S- | |Common Name=&&5S-Hydroxy- (6E,8Z,11Z,14Z,17Z) -eicosapentaenoic acid&&5-HEPE&& | ||
|UV Spectra= lambda max: 236nm epsilon : 23,000 | |UV Spectra= lambda max: 236nm epsilon : 23,000 | ||
|Source=The synthesis of 5(S)-HEPE from EPA by tissue homogenates has been demonstrated [[Reference:Kulkarni_PS:Kaufman_PL:Srinivasan_BD:,J. Ocul. Pharmacol.,1987,3,349|{{RelationTable/GetFirstAuthor|Reference:Kulkarni_PS:Kaufman_PL:Srinivasan_BD:,J. Ocul. Pharmacol.,1987,3,349}}]][[Reference:Kulkarni_PS:Srinivasan_BD:,Prostaglandins,1986,31,1159|{{RelationTable/GetFirstAuthor|Reference:Kulkarni_PS:Srinivasan_BD:,Prostaglandins,1986,31,1159}}]]. | |Source=The synthesis of 5(S)-HEPE from EPA by tissue homogenates has been demonstrated [[Reference:Kulkarni_PS:Kaufman_PL:Srinivasan_BD:,J. Ocul. Pharmacol.,1987,3,349|{{RelationTable/GetFirstAuthor|Reference:Kulkarni_PS:Kaufman_PL:Srinivasan_BD:,J. Ocul. Pharmacol.,1987,3,349}}]][[Reference:Kulkarni_PS:Srinivasan_BD:,Prostaglandins,1986,31,1159|{{RelationTable/GetFirstAuthor|Reference:Kulkarni_PS:Srinivasan_BD:,Prostaglandins,1986,31,1159}}]]. | ||
| Line 13: | Line 13: | ||
|Metabolism= | |Metabolism= | ||
|Symbol=5(S)-HEPE | |Symbol=5(S)-HEPE | ||
}} | |||
{{MassbankSpectra| | |||
UT000163 | |||
UT000164 | |||
UT000165 | |||
UT000166 | |||
UT000167 | |||
UT000168 | |||
UT000169 | |||
UT000170 | |||
UT000171 | |||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} | ||
Latest revision as of 00:00, 17 January 2014
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | DFA8118 |
| LipidMaps | - |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20503HO09 |
| 5S-Hydroxy- (6E,8Z,11Z,14Z,17Z) -eicosapentaenoic acid | |
|---|---|
| |
| Structural Information | |
| 5S-Hydroxy- (trans-6,cis-8,cis-11,cis-14,cis-17) -eicosapentaenoic acid | |
| |
| 5(S)-HEPE | |
| Formula | C20H30O3 |
| Exact Mass | 318.21949482599996 |
| Average Mass | 318.4504 |
| SMILES | C(CC=CCC=CCC=CC=CC(CCCC(O)=O)O)=CCC |
| Physicochemical Information | |
| The synthesis of 5(S)-HEPE from EPA by tissue homogenates has been demonstrated Kulkarni_PS et al. Kulkarni_PS et al.. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | λ max: 236nm ε : 23,000 |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
